Female Lung Cancer: Re-Analysis of National Survey of Lung Cancer in Korea, 2005

Abstract

Purpose: Female lung cancers have different clinical features and therapeutic results as compared to those of male lung cancers. The aim of this study was to analyze the differences of Korean men and women with lung cancer. Materials and Methods: We re-analyzed the results of a national survey of lung cancer conducted by the Korean Association for the Study of Lung Cancer in 2005. Results: Of the 8,788 patients, 2,124 (24.2%) were female. The mean age at the diagnosis was 62.5 years for the females and 64.8 years for the males and the difference was significant (p＜0.001). An age ＜50 years was more frequent for the women than for the men (16.2% vs. 7.9%, respectively; p=0.001). The stages between genders were different for the patients with non-small cell carcinoma (NSCLC) (p＜0.001), but not for the patients with small cell carcinoma. The overall survival time was longer for woman than that for the man (p＜0.001). However, the male patients had longer survival for the smokers with adenocarcinoma and the smokers with squamous cell carcinoma. The never smoker female patients had a better survival time than did the smoking female patients, but the male patient’ survival was not influenced by the smoking status. The stage-specific survival rates were better for the women at all stages